Baidu Stock News

Chinese market regulators have fined Alibaba (BABA), Baidu (BIDU) and JD.com (JD) on November 20 for failing to declare 43 deals, according to CNBC. The post Chinese Regulators Penalize Alibaba for Past Deal appeared first on Smarter Analyst .

Baidu Inc (NASDAQ: BIDU ) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY ) for use in designing vaccine and therapeutic products. The deal marks Baidu''s first such commercial deal with a major global drugmaker. Also Read: Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Full story available on Benzinga.com

Chinese tech giant Baidu Inc has licensed its algorithm for The post Baidu partners Sanofi on mRNA vaccine and therapy development appeared first on PageOne .

(RTTNews) - AI company Baidu.com, Inc. (BIDU) and French drug major Sanofi (SNYNF, SNY) have entered into an agreement to integrate Baidu''s messenger ribonucleic acid (mRNA) design optimization platform, LinearDesign, into Sanofi''s product design pipeline. Under the agreement, Sanofi will leverage the LinearDesign platform to contribute to the…

These stocks are moving the needle for AVs and can gain big as companies look for profitable ways to offer autonomous taxis. The post 3 Stocks to Buy If You Think Autonomous Taxis Will Take Off appear

Baidu Inc (NASDAQ: BIDU) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY) for use in designing vaccine and therapeutic products. The deal marks Baidu's firs

Baidu (NASDAQ:BIDU) had its price target cut by UBS Group from $240.00 to $220.00 in a research report report published on Thursday morning, The Fly reports. They currently have a buy rating on the information services providers stock. Several other research analysts have also commented on the stock. Zacks Investment Research raised shares of Baidu []

Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such

Shares of Alibaba Group Holding Limited (NYSE: BABA ), Baidu Inc. (NASDAQ: BIDU ), Li Auto Inc. (NASDAQ: LI ) and Xpeng Inc. (NYSE: XPEV ) fell in Hong Kong on Monday, while JD.Com Inc. (NASDAQ: JD ) and Tencent Holdings Inc . (OTC: TCEHY ) traded higher. Whats Moving : Alibabas shares have lost 0.5% to HKD 138.60 and technology company Baidus shares traded 1.1% lower at HKD 149.60 in Hong Kong, while tech conglomerate Tencents shares are up almost 0.5% to HKD 498.40. See Also: How To Buy Alibaba (BABA) Stock JD.Coms shares have gained 1.7% to HKD 358.20. The South China Morning Post reported that the e-commerce giant is among the four companies that will be added to the benchmark Hang Seng Index from Dec. 6. Electric vehicle maker Xpengs shares have lost 1.4% to HKD 184.60 and Li Autos shares are down Full story available on Benzinga.com

China is bringing the regulatory hammer down yet again on some of the country's largest tech firms.

Swiss Re is working with Baidu to develop insurance products for the Chinese technology giant''s autonomous driving business.

Several Chinese companies, including Alibaba, Baidu and JD.com will have $78,000 in fines levied against them stemming from 43 acquisitions that were said to breach the countrys anti-monopoly regulations, according to a Reuters report. The transactions, which were all said to be unreported, date as far back as 2012, according to the report. Tencent and []

Several Chinese companies, including Alibaba, Baidu and JD.com will have $78,000 in fines levied against them stemming from 43 acquisitions that were said to breach the country's anti-monopoly regulat